Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study

We conducted a prospective evaluation for the dynamic change of γδT cells in peripheral blood (PB) and N-telopeptide of type I collagen in urine (uNTX) of patients diagnosed with multiple myeloma (MM) who underwent their initial treatment with zoledronic acid (ZOA; Zobonic®, TTY, Taiwan). Between Ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao-Hung Wei, Yeu-Chin Chen, Shang-Yi Huang
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664624003140
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849419204047929344
author Chao-Hung Wei
Yeu-Chin Chen
Shang-Yi Huang
author_facet Chao-Hung Wei
Yeu-Chin Chen
Shang-Yi Huang
author_sort Chao-Hung Wei
collection DOAJ
description We conducted a prospective evaluation for the dynamic change of γδT cells in peripheral blood (PB) and N-telopeptide of type I collagen in urine (uNTX) of patients diagnosed with multiple myeloma (MM) who underwent their initial treatment with zoledronic acid (ZOA; Zobonic®, TTY, Taiwan). Between March 2012 and November 2015, a total of 35 patients were enrolled, including 25 newly diagnosed MM (NDMM) patients. The percentage of γδT cells in PB was assessed at 20 days prior to the first ZOA infusion, then at day 8, day 64, and day 85 after the infusion. Simultaneously, uNTX levels were measured as well. Thirty-three patients who had received at least one dose of ZOA were included in subsequent analysis. We identified three dynamic change patterns for γδT cells: fluctuated pattern, continuously increasing pattern, and continuously decreasing pattern. Among NDMM patients, those exhibiting a continuously increasing pattern showed a significantly shorter overall survival compared to those with the other two patterns combined (4.7 months vs. 92.9 months, p = 0.037). For uNTX, which levels significantly decreased following ZOA treatment. In conclusion, our findings reveal three distinct dynamic change patterns for γδT cells after ZOA initiation, with continuously increasing pattern being associated with a poor prognosis. These findings prompt further inquiry into the role of γδT cells in MM patients and support the suppressive nature of γδT cells and their associated tumor microenvironment.
format Article
id doaj-art-e45de17d08224ec5beec768c2c7e10ef
institution Kabale University
issn 0929-6646
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj-art-e45de17d08224ec5beec768c2c7e10ef2025-08-20T03:32:12ZengElsevierJournal of the Formosan Medical Association0929-66462025-07-01124762863210.1016/j.jfma.2024.07.011Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective studyChao-Hung Wei0Yeu-Chin Chen1Shang-Yi Huang2Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, TaiwanDepartment of Internal Medicine, Tri-Service General Hospital, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Corresponding author. National Taiwan University Hospital, B4 Room 0509, No.7, Chung-Shan South Road, 10002, Taipei, Taiwan.We conducted a prospective evaluation for the dynamic change of γδT cells in peripheral blood (PB) and N-telopeptide of type I collagen in urine (uNTX) of patients diagnosed with multiple myeloma (MM) who underwent their initial treatment with zoledronic acid (ZOA; Zobonic®, TTY, Taiwan). Between March 2012 and November 2015, a total of 35 patients were enrolled, including 25 newly diagnosed MM (NDMM) patients. The percentage of γδT cells in PB was assessed at 20 days prior to the first ZOA infusion, then at day 8, day 64, and day 85 after the infusion. Simultaneously, uNTX levels were measured as well. Thirty-three patients who had received at least one dose of ZOA were included in subsequent analysis. We identified three dynamic change patterns for γδT cells: fluctuated pattern, continuously increasing pattern, and continuously decreasing pattern. Among NDMM patients, those exhibiting a continuously increasing pattern showed a significantly shorter overall survival compared to those with the other two patterns combined (4.7 months vs. 92.9 months, p = 0.037). For uNTX, which levels significantly decreased following ZOA treatment. In conclusion, our findings reveal three distinct dynamic change patterns for γδT cells after ZOA initiation, with continuously increasing pattern being associated with a poor prognosis. These findings prompt further inquiry into the role of γδT cells in MM patients and support the suppressive nature of γδT cells and their associated tumor microenvironment.http://www.sciencedirect.com/science/article/pii/S0929664624003140Multiple myelomaT-lymphocyteZoledronic acid
spellingShingle Chao-Hung Wei
Yeu-Chin Chen
Shang-Yi Huang
Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
Journal of the Formosan Medical Association
Multiple myeloma
T-lymphocyte
Zoledronic acid
title Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
title_full Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
title_fullStr Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
title_full_unstemmed Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
title_short Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
title_sort dynamic changes in γδt cells and bone resorption markers after zoledronic acid in multiple myeloma a prospective study
topic Multiple myeloma
T-lymphocyte
Zoledronic acid
url http://www.sciencedirect.com/science/article/pii/S0929664624003140
work_keys_str_mv AT chaohungwei dynamicchangesingdtcellsandboneresorptionmarkersafterzoledronicacidinmultiplemyelomaaprospectivestudy
AT yeuchinchen dynamicchangesingdtcellsandboneresorptionmarkersafterzoledronicacidinmultiplemyelomaaprospectivestudy
AT shangyihuang dynamicchangesingdtcellsandboneresorptionmarkersafterzoledronicacidinmultiplemyelomaaprospectivestudy